Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....

Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : webmasterindia@abbott.com Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330 August 4, 2026 BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Scrip Code: 500488 Dear Sir/Madam, Subject: Intimation under Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 12, 2026, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2026. Please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and further to our intimation dated June 26, 2026, the Trading Window of the Company remains closed from Wednesday, July 1, 2026 to Friday, August 14, 2026 (both days inclusive). Kindly acknowledge the receipt of the same. For Abbott India Limited Sangeeta Shetty Company Secretary Membership No.: ACS 18865 Cc: National Securities Depository Limited Central Depository Services (India) Limited